Curosurf (Poractant Alfa) Market Size And Growth In 2026: Key Factors Shaping Future Demand
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Curosurf (Poractant Alfa) Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The historical growth can be attributed to a high occurrence of preterm births, the demonstrated effectiveness in treating respiratory distress syndrome, widespread adoption of neonatal intensive care units, clinical recommendations supporting surfactant therapy, and a reduction in neonatal mortality rates.
Growth during the projected period stems from a global rise in premature births, enhanced NICU facilities, better availability of neonatal care, increased understanding of early respiratory distress syndrome (RDS) intervention, and ongoing clinical verification. Concurrently, major developments anticipated during this timeframe involve an escalation in usage within neonatal intensive care units, a surge in the uptake of synthetic surfactants, heightened attention on managing preterm births, the establishment of uniform RDS treatment guidelines, and the proliferation of hospital-based neonatal treatments.
Get A Free Sample Report With In-Depth Market Insights:
Curosurf (Poractant Alfa) Market Demand Drivers Opening New Revenue Streams
The curosurf (poractant alfa) market is anticipated to expand due to the rising occurrence of respiratory ailments. These conditions encompass common issues impacting the lungs and respiration, including asthma, COPD, and lung cancer, which cause breathing difficulties and diminished lung capacity. The increase in respiratory disorder cases is attributed to heightened air pollution, worsening conditions like asthma, and an aging demographic, which leads to more age-related illnesses such as COPD. Poractant alfa is administered via an endotracheal tube to manage neonatal respiratory distress syndrome, enhancing lung function and aiding breathing in premature babies. As an illustration, the National Library of Medicine, a US-based medical library, stated in December 2023 that the worldwide count of chronic obstructive pulmonary disease (COPD) cases among individuals aged 25 and above is predicted to climb by 23% by 2050, reaching approximately 600 million. Consequently, the growing incidence of respiratory disorders is fueling the expansion of the curosurf (poractant alfa) market. The Curosurf (poractant alfa) market’s expansion is projected to be driven by the increasing occurrence of premature births. Premature births are defined as infants delivered prior to 37 weeks of gestation, contrasting with a typical full-term pregnancy of approximately 40 weeks. The surge in premature births is associated with factors such as advanced maternal age and the greater adoption of assisted reproductive technologies, which frequently result in multiple gestations. Poractant alfa is employed in the management of respiratory distress syndrome in premature infants by decreasing lung surface tension, thereby aiding lung expansion and enhancing oxygen exchange. For example, in July 2025, the Office for National Statistics, a UK-based government department, indicated that England and Wales registered 594,677 live births in 2024, representing an increase of 3,605 (0.6%) from the 591,072 births documented in 2023. Consequently, the rising frequency of premature births is propelling the Curosurf (poractant alfa) market forward.
Curosurf (Poractant Alfa) Market Segment Landscape: Which Areas Lead Development?
The curosurf (poractant alfa) market covered in this report is segmented –
1) By Type: Natural Poractant Alfa, Synthetic Poractant Alfa
2) By Sales Channel: Direct Sales, Distribution Channels, Online Marketplace
3) By Application: Pulmonary Edema, Respiratory Distress Syndrome, Other Respiratory Disorders
4) By End User: Hospitals, Clinics, Ambulance Services
Curosurf (Poractant Alfa) Market Trends Powering Strategic Industry Growth
Leading companies in the curosurf (poractant alfa) market are focused on developing advanced solutions, such as innovative inhaled gene therapy, to address unmet needs in respiratory conditions. Novel inhaled gene therapy is a cutting-edge technique where therapeutic genes are directly administered to the lungs via inhalation, typically through aerosolized particles or nanoparticles. For instance, in November 2024, AlveoGene, a UK-based gene therapy developer, obtained Rare Pediatric Disease Designation (RPDD) from the FDA for AVG-002. This is a novel inhaled gene therapy designed to treat lethal neonatal surfactant protein B (SP-B) deficiency, a severe genetic disorder resulting in respiratory failure in infants. SP-B deficiency, caused by mutations in the SFTPB gene, currently has limited treatment options, primarily relying on lung transplantation. AVG-002 utilizes AlveoGene’s InGenuity platform to deliver a functional SP-B gene directly to the lungs, showing promising results in preclinical studies.
Curosurf (Poractant Alfa) Market Industry Leaders And Competitive Landscape
Major companies operating in the curosurf (poractant alfa) market are Chiesi Farmaceutici S.p.A
View The Full Curosurf (Poractant Alfa) Market Report:
Curosurf (Poractant Alfa) Market Top Region By Revenue And Market Share
North America was the largest region in the curosurf (poractant alfa) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the curosurf (poractant alfa) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
